Catalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion Deal

Date:




The move marks Italy’s Angelini Pharma’s entry into the U.S. market.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related